Corrigendum to ‘Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery’ (International Journal of Pharmaceutics (2017) 517 (67-79) (S037851731631122X) (10.1016/j.ijpharm.2016.11.059));Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery

International Journal of Pharmaceutics

Volumn 517, Issue 1-2, 2017, Pages 67-79

  Iglesias, T ^a   Lopez de Cerain A ^a,b   Irache, J M ^a   Martin Arbella N ^a   Wilcox, M ^c   Pearson, J ^c   Azqueta, A ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b IdiSNA Navarra Institute for Health Research   (Spain)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Comet assay; Cytotoxicity; Genotoxicity; Mucus permeation; Polymeric nanoparticles; Viability

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; AMINODEXTRAN; DEXTRAN; GANTREZ COPOLYMER; MACROGOL 400; MANNOSAMINE; NANOPARTICLE; POLY(ANHYDRIDE) NANOPARTICLE; UNCLASSIFIED DRUG; DRUG CARRIER; MALEIC ACID DERIVATIVE; POLY(METHYL VINYL ETHER-CO-MALEIC ANHYDRIDE); POLYETHYLENE DERIVATIVE;

AQUEOUS SOLUTION; ARTICLE; CACO-2 CELL LINE; CELL METABOLISM; CELL VIABILITY; CYTOTOXICITY; DISPERSITY; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG DELIVERY SYSTEM; GENOTOXICITY; HT-29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR WEIGHT; MUCUS; PARTICLE SIZE; PH MEASUREMENT; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; ROOM TEMPERATURE; SURFACE PROPERTY; TARGET CELL; ZETA POTENTIAL; ANIMAL; CELL CULTURE TECHNIQUE; CELL SURVIVAL; CHEMISTRY; COMET ASSAY; DRUG EFFECTS; INTESTINE MUCOSA; METABOLISM; ORAL DRUG ADMINISTRATION; PERMEABILITY; PIG; STOMACH MUCOSA;

ADMINISTRATION, ORAL; ANIMALS; CACO-2 CELLS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; COMET ASSAY; DNA BREAKS; DRUG CARRIERS; GASTRIC MUCOSA; HT29 CELLS; HUMANS; INTESTINAL MUCOSA; MALEATES; NANOPARTICLES; PERMEABILITY; POLYETHYLENES; SURFACE PROPERTIES; SWINE;

EID: 85001075187     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2017.10.020     Document Type: Erratum

References (48)

1. Agüeros, M., Campanero, M.A., lrache, J.M., Simultaneous quantification of different cyclodextrins and Gantrez by HPLC with evaporative light scattering detection. J. Pharm. Biomed. Anal. 39:3–4 (2005), 495–502, 10.1016/j.jpba.2005.04.034.
2. Agüeros, M., Areses, P., Campanero, M.A., Salman, H., Quincoces, G., Peñuelas, I., Irache, J.M., Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles. Eur. J. Pharm. Sci. 37:3–4 (2009), 231–240, 10.1016/j.ejps.2009.02.010.
3. Agüeros, M., Zabaleta, V., Espuelas, S., Campanero, M.A., Irache, J.M., Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles. J. Controlled Release 145:1 (2010), 2–8, 10.1016/j.jconrel.2010.03.012.
4. Ahmad, Z., Pandey, R., Sharma, S., Khuller, G.K., Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles. Int. J. Antimicrob. Agents 31:2 (2008), 142–146, 10.1016/j.ijantimicag.2007.10.017.
5. Ahmad, S.I., Yokoi, M., Hanaoka, F., Identification of new scavengers for hydroxyl radicals and superoxide dismutase by utilising ultraviolet A photoreaction of 8-methoxypsoralen and a variety of mutants of Escherichia coli: implications on certain diseases of DNA repair deficiency. J. Photochem. Photobiol. B 116 (2012), 30–36, 10.1016/j.jphotobiol.2012.07.004.
6. ® AN as a new polymer for the preparation of ligand–nanoparticle conjugates. J. Controlled Release 83:3 (2002), 321–330, 10.1016/S0168-3659(02)00015-9.
7. Arbós, P., Campanero, M.A., Arangoa, M.A., Irache, J.M., Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines. J. Controlled Release 96:1 (2004), 55–65, 10.1016/j.jconrel.2004.01.006.
8. Azqueta, A., Collins, A.R., The essential comet assay: a comprehensive guide to measuring DNA damage and repair. Arch. Toxicoly 87:6 (2013), 949–968, 10.1007/s00204-013-1070-0.
9. Azqueta, A., Dusinska, M., The use of the comet assay for the evaluation of the genotoxicity of nanomaterials. Frontriers Genet. 6 (2015), 239–243, 10.3389/fgene.2015.00239.
10. Beloqui, A., Solinís, M.A., Rieux, A.d., VRodríguez-Gascón, Préat, Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs. Int. J. Pharm. 468:1–2 (2014), 105–111, 10.1016/j.ijpharm.2014.04.027.
11. Bernkop-Schnürch, A., Nanocarrier systems for oral drug delivery: do we really need them?. Eur. J. Pharm. Sci. 49:2 (2013), 272–277, 10.1016/j.ejps.2013.03.008.
12. Brooks, D., Okeefe, P., Buncke, H.J., Dextran induced acute renal failure after microvascular muscle transplantion. Plast. Reconstr. Surg. 108:7 (2001), 2057–2060.
13. Carrillo-Conde, B., Song, E.H., Chavez-Santoscoy, A., Phanse, Y., Ramer-Tait, A.E., Pohl, N.L., Wannemuehler, M.J., Bellaire, B.H., Narasimhan, B., Mannose-functionalized pathogen-like polyanhydride nanoparticles target c-type lectin receptors on dendritic cells. Mol. Pharm. 8:5 (2011), 1877–1886, 10.1021/mp200213r.
14. Collins, A.R., Azqueta, A., Single-cell gel electrophoresis combined with lesion-specific enzymes to measure oxidative damage to DNA. Methods Cell Biol. 112 (2012), 69–92.
15. De Jong, W.H., Borm, P.J., Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 3:2 (2008), 133–149.
16. Easo, S.L., Mohanan, P.V., Dextran stabilized iron oxide nanoparticles: synthesis, characterization and in vitro studies. Carbohydr. Polym. 92:1 (2013), 726–732, 10.1016/j.carbpol.2012.09.098.
17. Ensign, L.M., Cone, R., Hanes, J., Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv. Drug Deliv. Rev. 64:6 (2012), 557–570, 10.1016/j.addr.2011.12.009.
18. Friedl, H., Dünnhaupt, S., Hintzen, F., Waldner, C., Parikh, S., Pearson, J.P., Wilcox, M.D., Bernkop-Schnürch, A., Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying drugdelivery systems. J. Pharm. Sci. 102:12 (2013), 4406–4419, 10.1002/jps.23757.
19. Gniewek, P., Kolinski, A., Coarse-grained modeling of mucus barrier properties. Biophys. J. 102:2 (2012), 195–200, 10.1016/j.bpj.2011.11.4010.
20. Handy, R.D., Owen, R., Valsami-Jones, E., The ecotoxicology of nanoparticles and nanomaterials: current status, knowledge gaps, challenges, and future needs. Ecotoxicology 17:5 (2008), 315–325, 10.1007/s10646-008-0206-0.
21. Huet, C., Sahuquillo-Merino, C., Coudrier, E., Louvard, D., Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation. J. Cell Biol. 105:1 (1987), 345–402.
22. Hunter, A.C., Elsom, J., Wibroe, P.P., Moghimi, S.M., Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Nanomed. Nanotechnol. Biol. Med. 8:1 (2012), 5–20, 10.1016/j.nano.2012.07.005.
23. Inchaurraga, L., Martín-Arbella, N., Zabaleta, V., Quincoces, G., Peñuelas, I., Irache, J.M., In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration. Eur. J. Pharm. Biopharm. 97:Pt. A (2015), 280–289, 10.1016/j.ejpb.2014.12.021.
24. Irache, J., Huici, M., Konecny, M., Espuelas, S., Campanero, M., Arbós, P., Bioadhesive properties of Gantrez nanoparticles. Molecules 10:1 (2005), 126–145, 10.3390/10010126.
25. Jain, A.K., Swarnakar, N.K., Godugu, C., Singh, R.P., Jain, S., The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials 32:2 (2011), 503–515, 10.1016/j.biomaterials.2010.09.037.
26. Jaiswal, S., Bhattacharya, K., McHale, P., Duffy, B., Dual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity. J. Mater. Sci. 26:1 (2015), 5367–5377, 10.1007/s10856-014-5367-1.
27. Kumar, M., Trivedi, N., Reddy, C.R.K., Jha, B., Toxic effects of imidazolium ionic liquids on the green seaweed ulva lactuca: oxidative stress and DNA damage. Chem. Res. Toxicol. 24:11 (2011), 1882–1890, 10.1021/tx200228c.
28. Lai, S.K., Wang, Y., Hanes, J., Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliv. Rev. 61:2 (2009), 158–171, 10.1016/j.addr.2008.11.002.
29. Landsiedel, R., Fabian, E., Ma-Hock, L., Wohlleben, W., Wiench, K., Oesch, F., Van Ravenzwaay, B., Toxico-/biokinetics of nanomaterials. Arch. Toxicol. 86:7 (2012), 1021–1060, 10.1007/s00204-012-0858-7.
30. Lesuffleur, T., Barbat, A., Dussaulx, E., Zweibaum, A., Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res. 50:19 (1990), 6334–6377.
31. Li, Z., Han, X., Zhai, Y., Lian, H., Zhang, D., Zhang, W., Wang, Y., He, Z., Liu, Z., Sun, J., Critical determinant of intestinal permeability and oral bioavailability of pegylated all trans-retinoic acid prodrug-based nanomicelles: chain length of poly (ethylene glycol) corona. Colloids Surf. B: Biointerfaces 130 (2015), 133–140, 10.1016/j.colsurfb.2015.03.036.
32. Liu, H., Liu, T., Wang, H., Li, L., Tan, L., Fu, C., Nie, G., Chen, D., Tang, F., Impact of PEGylation on the biological effects and light heat conversion of gold nanoshells on silicananorattles. Biomaterials 34:28 (2013), 6967–6975, 10.1016/j.biomaterials.2013.05.059.
33. Lu, Y., Qi, J., Wu, W., Absorption disposition and pharmacokinetics of nanoemulsions. Curr. Drug Metab. 13:4 (2012), 396–417.
34. Mittal, G., Sahana, D.K., Bhardwaj, V., Ravi Kumar, M.N., Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behaviour in vitro and in vivo. J. Controlled Release 119:1 (2007), 77–85, 10.1016/j.jconrel.2007.01.016.
35. Nagai, N., Ono, H., Hashino, M., Ito, Y., Okamoto, N., Shimomura, Y., Improved corneal toxicity and permeability of tranilast by the preparation of ophthalmic formulations containing its nanoparticles. J. Oleo. Sci. 63:2 (2014), 177–186, 10.5650/jos.ess13082.
36. Nel, A., Xia, T., Mädler, L., Li, N., Toxic potential of materials at the nanolevel. Science 311:5761 (2006), 622–627, 10.1126/science.1114397.
37. Ojer, P., Neutsch, L., Gabor, F., Irache, J., López de Cerain, A., Cytotoxicity and cell interaction studies of bioadhesive poly(anhydride) nanoparticles for oral antigen/drug delivery. J. Biomed. Nanotechnol. 9:11 (2013), 1891–1903, 10.1166/jbn.2013.1695.
38. Porfire, A.S., Zabaleta, V., Gamazo, C., Leucuta, S.E., Irache, J.M., Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles. Int. J. Pharm. 390:1 (2010), 37–44, 10.1016/j.ijpharm.2009.08.017.
39. Salman, H.H., Gamazo, C., Campanero, M.A., Irache, J.M., Salmonella-like bioadhesive nanoparticles. J. Controlled Release 106:1–2 (2005), 1–13, 10.1016/j.jconrel.2005.03.033.
40. Salman, H.H., Gamazo, C., Campanero, M., Irache, J.M., Bioadhesive mannosylated nanoparticles for oral drug delivery. J. Nanosci. Nanotechnol. 6:9–10 (2006), 3203–3209.
41. Salman, H.H., Gamazo, C., Smidt, P.C., Russell-Jones, G., Irache, J.M., Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B (12)-Gantrez nanoparticles. Pharm. Res. 25 (2008), 2859–2868, 10.1007/s11095-008-9657-5.
42. Salman, H.H., Irache, J.M., Gamazo, C., Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination. Vaccinne 27:35 (2009), 4784–4790, 10.1016/j.vaccine.2009.05.091.
43. Stella, V.J., He, Q., Cyclodextrins. Toxicol. Pathol. 36 (2008), 30–42, 10.1177/0192623307310945.
44. Wu, J., Shen, Q., Fang, L., Sulfobutyletherβ-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel. Drug Dev. Ind. Pharm. 39:7 (2013), 1010–1019, 10.3109/03639045.2012.694588.
45. Yoncheva, K., Gómez, S., Campanero, M.A., Gamazo, C., Irache, J.M., Bioadhesive properties of pegylated nanoparticles. Expert Opin. Drug Deliv. 2:2 (2005), 205–218, 10.1517/17425247.2.2.205.
46. Yoncheva, K., Doytchinova, I., Irache, J.M., Different approaches for determination of the attachment degree of polyethylene glycols to poly(anhydride) nanoparticles. Drug Dev. Ind. Pharm. 36:6 (2010), 676–680, 10.3109/03639040903443434.
47. Zabaleta, V., Ponchel, G., Salman, H., Agüeros, M., Vauthier, C., Irache, J.M., Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study. Eur. J. Pharm. Biopharm. 81:3 (2012), 514–523, 10.1016/j.ejpb.2012.04.001.
48. Zaki, N.M., Hafaez, M.M., Enhanced antibacterial of ceftriaxone sodium- loades chitosan nanoparticles against intracellular Salmonella typhimurium. AAPS PharmSciTech 13:2 (2012), 411–421, 10.1208/s12249-012-9758-7.